Delivery Order SPE2DB22D3016-SPE2DB24FAYT3

Award Date 6/18/24
Potential Completion Date 6/20/24
Potential Value $1.1K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award to AmerisourceBergen Drug Corp, Corporate Office Division, is for the delivery of MOUNJARO 10 MG/0.5 ML PEN 0.5ML, a pharmaceutical product. The contract was awarded by the Defense Logistics Agency (DLA) Troop Support Medical, a division of the Department of Defense, and has a ceiling value of $2,802.89. The contract is a Delivery Order with a Firm Fixed Price pricing type, has no set-aside designation, and has an ultimate completion date of August 28, 2024....
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division, a major pharmaceutical distributor, is for the supply of the medication MOUNJARO 7.5 MG/0.5 ML PEN 0.5ML to the Defense Logistics Agency (DLA). The $1,506.00 delivery order contract has an ultimate completion date of April 30, 2024. Amerisourcebergen holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the primary vehicle for the company to deliver a...
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the delivery of the pharmaceutical product MOUNJARO 15 MG/0.5 ML PEN 0.5ML. The $3,156.00 firm fixed price delivery order was issued by the Defense Logistics Agency (DLA), which is a defense agency. The contract has a completion date of May 7, 2024. Amerisourcebergen, a major pharmaceutical distribution company, holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical as...
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office division is a delivery order valued at $33,494.24 for the supply of MOUNJARO 5 MG/0.5 ML PEN 0.5ML, a pharmaceutical product. The contract is awarded by the Defense Logistics Agency (DLA), a defense agency, and has an ultimate completion date of August 27, 2024. Amerisourcebergen, a major pharmaceutical distributor, has been awarded this contract without any set-aside designation. The company also holds several...
This federal contract award to Amerisourcebergen Drug Corp, the Corporate Office division of Amerisourcebergen Corporation, is for the delivery of the pharmaceutical product MOUNJARO 15 MG/0.5 ML PEN 0.5ML. The $1,052.00 firm fixed-price contract was awarded by the Defense Logistics Agency (DLA), a defense agency, and has a completion date of June 26, 2024. Amerisourcebergen holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which serves as the primary...
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the provision of 4564484798 MOUNJARO 15 MG/0.5 ML PEN 0.5ML, a pharmaceutical product, to the Defense Logistics Agency (DLA). The $3,156.00 delivery order contract has a firm fixed price and is set to be completed by May 6, 2024. Amerisourcebergen, a major supplier of pharmaceuticals and medical supplies to the federal government, holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA...
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the pharmaceutical product MOUNJARO 10 MG/0.5 ML PEN 0.5ML. The $2,367.00 firm fixed price delivery order was awarded by the Defense Logistics Agency (DLA), a component of the Department of Defense, with an ultimate completion date of June 17, 2024. Amerisourcebergen, one of the largest pharmaceutical distribution companies, holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop...
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the pharmaceutical product MOUNJARO 15 MG/0.5 ML PEN 0.5ML. The $2,439.79 firm-fixed-price delivery order was issued by the Defense Logistics Agency (DLA), a defense agency, and has a completion date of May 3, 2024. Amerisourcebergen holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical to provide a wide range of pharmaceutical products and medical...
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the delivery of Mounjaro 10 mg/0.5 ml pens to the Defense Logistics Agency (DLA) under a $1,382.00 firm fixed price delivery order. The contract has an ultimate completion date of April 23, 2024. Amerisourcebergen is a major supplier of pharmaceutical products and medical supplies to the U.S. federal government, particularly the Department of Defense (DoD) and Department of Veterans Affairs (VA)...
This federal contract award is for a delivery order placed by the Defense Logistics Agency (DLA), a defense agency, with Amerisourcebergen Drug Corp's Corporate Office Division. The $43,451.24 firm fixed-price contract is for the supply of MOUNJARO 10 MG/0.5 ML PEN 0.5ML, a pharmaceutical product. The contract has an ultimate completion date of August 21, 2024, and was awarded on August 20, 2024. As a major pharmaceutical distributor, Amerisourcebergen has been awarded numerous federal...
  • SPE2DB22D3016
    Indefinite Delivery Contract
  • SPE2DB22D3016-SPE2DB24FAYT3
    Delivery Order

This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the delivery of MOUNJARO 10 MG/0.5 ML PEN 0.5ML medication to the Defense Logistics Agency (DLA). The $1,053.68 firm fixed-price delivery order has a completion date of June 20, 2024. Amerisourcebergen, a major pharmaceutical distribution company, holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical to provide a comprehensive range of pharmaceutical products and medical supplies to DLA facilities supporting the Department of Defense worldwide. This order is not associated with a set-aside program. Amerisourcebergen's extensive supply chain capabilities and expertise in government contracting allow it to efficiently fulfill critical medical product requirements for the U.S. federal government.

Generated 9/17/24, 10:00 AM